Utilization of Surveillance Colonoscopy in Community Practice Robert E. Schoen, Paul F. Pinsky, Joel L. Weissfeld, Lance A. Yokochi, Douglas J. Reding, Richard B. Hayes, Timothy Church, Susan Yurgalevich, V. Paul Doria–Rose, Tom Hickey, Thomas Riley, Christine D. Berg  Gastroenterology  Volume 138, Issue 1, Pages 73-81 (January 2010) DOI: 10.1053/j.gastro.2009.09.062 Copyright © 2010 AGA Institute Terms and Conditions

Figure 1 Kaplan–Meier probability curve for surveillance colonoscopy use by year from baseline diagnostic colonoscopy for subjects with AA (solid line), ≥3 NAAs (dotted line), 1–2 NAAs (dashed line), and NA (thin line). Gastroenterology 2010 138, 73-81DOI: (10.1053/j.gastro.2009.09.062) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Use of surveillance colonoscopy by baseline histologic status. The pathways on the far right demonstrate utilization in the subgroup without a family history of CRC, with complete, adequate colonoscopy, and without symptoms. Gastroenterology 2010 138, 73-81DOI: (10.1053/j.gastro.2009.09.062) Copyright © 2010 AGA Institute Terms and Conditions

Figure 2 Use of surveillance colonoscopy by baseline histologic status. The pathways on the far right demonstrate utilization in the subgroup without a family history of CRC, with complete, adequate colonoscopy, and without symptoms. Gastroenterology 2010 138, 73-81DOI: (10.1053/j.gastro.2009.09.062) Copyright © 2010 AGA Institute Terms and Conditions